Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate

DRUG: TR-701 di-sodium phosphate salt
DRUG: TR-701 free acid phosphate

PHASE1

Phase

COMPLETED

Status

Enrollment

INDUSTRY

Sponsor class

Conditions

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)